Let BC PharmaCare hear “Your Voice” on tofacitinib for rheumatoid arthritis
Taken orally, tofacitinib (Xeljanz®) is now being considered for coverage under the British Columbia Ministry of Health’s PharmaCare program. By filling out a questionnaire on a website called Your Voice, you can provide feedback about tofacitinib for the treatment of rheumatoid arthritis (RA).
You can give input if you are a B.C. resident and have RA, a caregiver to someone with RA, or if your group represents people who live with RA.
The input is reviewed by the Drug Benefit Council, which then gives recommendations on whether a medication should be covered, and how, by BC PharmaCare. BC PharmaCare then makes a decision based on those recommendations and available resources. Policies and plans already in place also factor in the decision making process.
It is an opportunity for you to share your perspectives on medication decisions that affect you or someone you provide care for. Continue reading →
With a record 122,150,772 million tweets, texts, calls and shares on Bell Let’s Talk Day, yesterday was a big milestone for Canada’s mental health initiatives – a total of $6,107,538.60 was raised. Arthritis Broadcast Network proudly joined the conversation to create awareness for how mental illness can affect those living with Fibromyalgia. Today, we highlight the relationship between arthritis and depression, specifically in rheumatoid arthritis. Continue reading →
The American College of Rheumatology’s (ACR) 2014 Annual Meeting will be held at the Boston Convention and Exhibition Center from Friday, November 14 to Wednesday, November 19 in Boston, Massachusetts. The ACR Annual Meeting is rheumatology’s premier scientific meeting for those involved in research or delivery of rheumatologic care or services.
The event is an opportunity for rheumatology experts from around the world to gather in one place to discuss the latest innovations in prevention, diagnosis, and treatment of rheumatic diseases. There will also be presentations on the latest discoveries and research that are transforming rheumatic disease care.
Image courtesy of hywards at FreeDigitalPhotos.net
Have you recently been recommended to take BIOLOGIC medications for Rheumatoid Arthritis?
The latest online tool to help make your treatment decisions.
We are looking for people with rheumatoid arthritis to test a new online tool that helps to make decisions about using biologic medications.
If you have been recommended to consider using a biologic by your doctor but have not started yet, we invite you to participate in this study.
You may be eligible if you:
Have rheumatoid arthritis
See a rheumatologist
Have received a recommendation to consider biologic therapy
Have a valid email and internet access
The study will take about two hours to complete over a span of four to six weeks, and can be completed remotely. Any information you provide will be completely confidential. An honorarium will be provided for your time.
If you would like more information, please contact Jasmina Memetovic, Research Coordinator by phone at 604-207-4007, toll free 1-877-871-4575, or email email@example.com.
Ms. Catherine Hofstetter is the inaugural recipient of the 2014 Qualman-Davies Arthritis Consumer Community Leadership Award.
A successful business owner living with rheumatoid arthritis, Cathy has been an arthritis advocate for seventeen years championing the patient experience, promoting more effective treatments and healthcare policies, and motivating and mentoring consumers to become involved in research decision-making and positive reform of the healthcare system.